Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties

ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients   Mumbai, Maharashtra [India], June 21: According to recent stats, 2.77 crores of COVID-19 sufferers were recovered from 2.88 crores cases in India. All corporate offices and businesses want to operate outdoors but worry much about the Post Covid difficulties and resolutions. While […]

Read More